Summary
CRITICAL: Human pharmacological data on 2C-T-7-NBOMe are virtually nonexistent. The active dose range has not been established in scientific literature. All dosage estimates are extrapolated from structural-activity relationships with related NBOMes (25T2-NBOMe, 25T4-NBOMe) and limited anecdotal reports. This compound may inherit the severe toxicity profile of its parent 2C-T-7, which has been associated with multiple fatalities. NBOMe compounds have been linked to severe vasospasm, seizures, serotonin syndrome, and several deaths at milligram-level dosing.
Dose Information
| ROA | Light | Common | Strong | Heavy |
|---|---|---|---|---|
| Oral | - | - | 1.0-1.5mg | 1.5ยตg+ |
Light
Common
Strong
Heavy
Onset, Duration & After-effects
| ROA | Onset | Comeup | Peak | Offset | After Effects |
|---|---|---|---|---|---|
| Sublingual | 15-45 min | 30-60 min | 2-4 hrs | 2-4 hrs | 2-8 hrs |
| Insufflated | 5-15 min | 15-30 min | 2-3 hrs | 1-3 hrs | 2-6 hrs |
| Oral | 30-90 min | 45-90 min | 3-5 hrs | 2-4 hrs | 4-12 hrs |
Tolerance
Build-up
develops rapidly after a single use (serotonergic psychedelic)
Reset
7โ14 days for baseline
Effects
Positive
- Stimulation
- Physical euphoria
Negative
- Vasoconstriction
- Tachycardia
- Nausea
- Restlessness
- Headaches
- Insomnia
- Increased heart rate
- Sedation
Positive
- Euphoria
- Empathy enhancement
- Conceptual thinking
- Analysis enhancement
Negative
- Thought loops
- Anxiety
- Memory suppression
- Confusion
- Motor control loss
- Time distortion
Positive
- Visual enhancement
- Pattern recognition enhancement
- Colour enhancement
- Color enhancement
- Tracers
- Tactile enhancement
- Increased music appreciation
Negative
- Visual distortions
- Drifting
- Auditory distortion